Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Sodium Ibandronate Injection

Approval Number

国药准字H20194060

Company成都苑东生物制药股份有限公司

Registration Date

November 10, 2021

Previous Approval Numbers

国药准字H20194060

Drug Information

Generic Name

伊班膦酸钠注射液

Dosage Form

注射剂

Strength

4ml:4mg(以伊班膦酸计)

Drug Type

化学药品

Registration Date

November 10, 2021

Company Information

Applicant Company

Company Name成都苑东生物制药股份有限公司

Company Address

成都高新区西源大道8号

Manufacturing Company

Company Name成都苑东生物制药股份有限公司

Company Address

成都高新区西源大道8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy